Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPotent CB1 receptor agonist (Ki = 2.2 nM). Exhibits analgesic, motor depressant, anticonvulsant and hypothermic effects in vivo.
分子量 | 318.49 |
公式 | C21H34O2 |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 70434-82-1 |
PubChem ID | 90488849 |
InChI Key | OWPXDWMENLSANZ-OPRWNZNUSA-N |
Smiles | CC(CCCCCC)(C)C(C=C2O)=CC=[C@@]2[C@H]1CCC[C@@H](O)C1.CC(CCCCCC)(C)C(C=C4O)=CC=[C@@]4[C@@H]3CCC[C@H](O)C3 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Weissman et al (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J.Pharmacol.Exp.Ther. 223 516 PMID: 6290642
Melvin et al (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol.Pharmacol. 44 1008 PMID: 8246904
Huffman et al (2008) Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorg.Med.Chem. 16 322 PMID: 17919913
关键词: (±)-CP 47497, (±)-CP 47497 supplier, Potent, CB1, agonists, cannabinoids, Receptors, (±)-CP47497, cb1r, 3500, Tocris Bioscience
目前没有该产品的评论。 Be the first to review (±)-CP 47497 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.